-+ 0.00%
-+ 0.00%
-+ 0.00%

TELITACICEPT RECEIVES NMPA CONDITIONAL APPROVAL FOR THE TREATMENT OF IGA NEPHROPATHY IN CHINA

Reuters·06/08/2026 12:30:01

Please log in to view news